Prosecution Insights
Last updated: August 18, 2026

Examiner: LEE, ANDREW P

Tech Center 1600 • Art Units: 1621 1628 1629 1691

This examiner grants 48% of resolved cases

Performance Statistics

48.4%
Allow Rate
-11.6% vs TC avg
639
Total Applications
+23.3%
Interview Lift
1208
Avg Prosecution Days
Based on 587 resolved cases, 2023–2026

Rejection Statute Breakdown

1.0%
§101 Eligibility
7.8%
§102 Novelty
57.4%
§103 Obviousness
20.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19446884 METHODS FOR THE TREATMENT OF ABNORMAL INVOLUNTARY MOVEMENT DISORDERS Final Rejection Auspex Pharmaceuticals LLC
19446877 METHODS FOR THE TREATMENT OF ABNORMAL INVOLUNTARY MOVEMENT DISORDERS Final Rejection Auspex Pharmaceuticals LLC
19446867 METHODS FOR THE TREATMENT OF ABNORMAL INVOLUNTARY MOVEMENT DISORDERS Final Rejection Auspex Pharmaceuticals LLC
18560036 HERBICIDAL COMPOSITIONS Non-Final OA SYNGENTA CROP PROTECTION AG
16972873 Modified Nucleobases with Uniform H-Bonding Interactions, Homo- and Hetero-Basepair Bias, and Mismatch Discrimination Final Rejection Carnegie Mellon University
17232397 METHOD FOR OBTAINING INFORMATION ON RISK OF REDUCED RESPIRATORY FUNCTION IN PATIENT WITH INTERSTITIAL PNEUMONIA Final Rejection SYSMEX CORPORATION

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month